0001104659-21-068962.txt : 20210622 0001104659-21-068962.hdr.sgml : 20210622 20210518182153 ACCESSION NUMBER: 0001104659-21-068962 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20210518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Armata Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000921114 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911549568 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 4503 GLENCOE AVENUE CITY: MARINA DEL REY STATE: CA ZIP: 90292 BUSINESS PHONE: 310-665-2928 MAIL ADDRESS: STREET 1: 4503 GLENCOE AVENUE CITY: MARINA DEL REY STATE: CA ZIP: 90292 FORMER COMPANY: FORMER CONFORMED NAME: AmpliPhi Biosciences Corp DATE OF NAME CHANGE: 20130222 FORMER COMPANY: FORMER CONFORMED NAME: TARGETED GENETICS CORP /WA/ DATE OF NAME CHANGE: 19940331 CORRESP 1 filename1.htm

May 18, 2021

VIA EDGAR SUBMISSION

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

Re:

Armata Pharmaceuticals, Inc. (the “Company”)
Registration Statement on Form S-3 (File No. 333-256104) (the “Registration Statement”)

Dear Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), the Company hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on Thursday, May 20, 2021, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.

If you have any questions regarding this request, please contact our outside counsel, Faith Charles of Thompson Hine LLP, at (212) 908-3905 or the undersigned at (310) 665-2928 x203. Please also call Faith Charles as soon as the Company’s Registration Statement on Form S-3 has been declared effective. Thank you for your attention to this matter.

	Sincerely,

	ARMATA PHARMACEUTICALS, INC.


	By:	/s/ Todd Patrick
	Name: Todd Patrick
	Title: Chief Executive Officer

cc: Faith Charles, Thompson Hine LLP

GRAPHIC 2 tm2116038d2_correspimg001.jpg GRAPHIC begin 644 tm2116038d2_correspimg001.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# H'!PD'!@H)" D+"PH,#QD0#PX. M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_ MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T] M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P 1" !? )@# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#V:BBB@ HH MHH **** "BBB@ HJ%KF)60;U^QE_>!E!#9PX[#C]>E4HM MDN21HT5FP:F)50Y4[XBX .$\Q2L>&0><%#C^(GV%W:"4^2T5%B\U-G67:Y3S%$T7[T#!'WE&T=/7U-4I+PDR.,G+)<+NR#GH>IZ?RJJ\@1 MR%_U<3AU4V!Z>Y]ZN:;9-/,$7[H+Q @\$$9'X?G77RJ*N<7-*;L:5@A: M0*. )9!@=PRY]:W+2(Q0QACC$87\J@6!;6-0JC>P!./4#!Q51M3^?"LK>PSS M_GG\!7!5K*YZE##2:N;=%9-MJP?ECN'MW_\ KD]!6HCAQD&LXR4MBYTY0>HZ MBBBJ("BBB@ HHHH **** "BH;FZALX&FN)%CC7JQJO::S87\WE6MRDDF,[1G MI346U>Q+E%.S>I>J*9B!A6 /4[AD8[TES=0V<#37$@CC7JQ[50/B72#_ ,OT M7Z_X4XQD]4A2G&.C=BC>Q3')"6A"'Y,1%CY!ZK]362^GW@?.&81M@?PKL/8 M4",F,ANF".*ZG2+$VUN#(/WC!=WU Q4]G<6M[#YUK(DL><;E]1 M3;S5K+3W5+NX2)F&0#W%3.I.?NV*ITH4_>N6G19%PPXK'U+368EHUR#U X_R M>@_.M6VN8KN!9K=Q)&W1AWIMY>6]C!YMU*L<><;F]:YY4^;W3KIUG3]Y/0YI M;2X0C@Y'&['3U/N>PK5T]IUQO3 Z8S^GX=?SJS9ZC8:@[):7"2L@R0O85'479&M3&1G&[M8T5.0#2UE#Q+I _Y?HOU_PJ];WD M%U;?:()5>'GYQTXZULX26Z.53C)Z,GHK-B\0:7/,D4=Y&SN=JCGDUI4G%QW0 M1DI;,****10444A(4$DX Y)H X_QYJ&%@L4/7]XX_E7.Z=/+HVKVTTJLN-K$ M>J-_]:C4[]=0UR6YEW&$R8P.NP>E6/$>J6>K3PRVD4D;(FQ@P'([5ZU.'+%0 MMON>+5J*&] AUM+DS2R1F(@#;COFM)M0 M^W> 9 QS)"5C;\",?I7,P)=K933V[R+"C!9-C$=>F:SHPE&G**=G/9MVH6T(.=D98CT)/_UJ=X*TZRN) MC)!O3ZCK^E8_B*__M'6IY ,>_Z%C1+B31?$$/GC9SLD![!O\BNE\0^&(KIKK43<.KB/ M=L &.!7,>(=1M=5U 7-JCQDH X8 EWJZAIL%RI'SJ"?8]ZX&]U2PN/#UM80Q2K- 00Q P3_%6 MSX$O]T<]BYY7]X@]N]3B8N=/F:V_(O"25.IRIW37XG84445YQZ@50UJ.ZETJ M>*R4--(NT9., ]35^L_5V588/,$&CGE? M5H$9 N$7=GGUXK4U#PI826$RVEJB7!7]VV3UJRLOEV-P\;2F%95\LG).W*YQ MW(ZU-;W7VC4W"B55$(^5T*\[CV-:/%3E*]R%@81@U;0Y&U\.:S!97=L84V3J M.-XZ@YK5\,Z!/9VM[!J,2[+@ 8#9R.:UK.>1M0D9RWE3Y\L=AL./USG\*IQR MYG<1M,;LW3!>6V[0W(],8HGC)25K;A3RZ,97OLOS_IF%;^&M8TK5?/LE1TC? MY27QO7T(I\'AO4IO$"7EU BQ-/YCCS,D#-=$]X]KK%R9'_<&-0JD]'P3^O\ M2GVD\L&E3R3,3*C/UYP<\#\^*KZ[)MZ$?V;%):Z:/[RGXKT275K:%K55,\3= MSC*GK5R#2Q;>'C8(,L82IYZL1S^M)%--;Z1=+)(7N+96RQ^F1_.K-I:B';(L MDA#(-RLV03Z\]ZS5>3BH]C66&C&4IWU>AQ-MX:UNUCN$CB0">/RV_>#ID&M/ MP_X1$8F;5X$IXK8T9HY8T=O/,WS99MVT_,1]*DEF<6+,'.?/VYSV MWU;QDY1[7,UET(3MO;34S]6\)V)0D M\1V8<'YL8KNHW@ MX-J<=';_ (!S/AO0-1TO4'N)X4P(F"X<')[57L?"E_/JZS:G&AA9R\GSYW>U M=3IL+R00733.7<$R G(;/MVQ2-<2#5@Q^3_C7.Z7X=U72M;CN(XU:%'()#CE#76VSLVH7BEB54I@ M>GRU7NCMO7-S)-%'\ODR+G:OKGMG/K4K$SC%];]RG@X3DNC6NAIT445F6%07 M-O\ :/*^;;Y<@?IUQ4]%#5QIM.Z(YXO.B*9QD@Y^AS_2F/;DW+S*^"T7ECCI MSG-3T4K#4FC/BT>&#[.T/R21$$OS\WK^=/&G[0,2?.)S,#CU/(_(U=HIAIDFG"6$PNV8VF\QQCJ,YQ5VBCE0E4DNI273( MD,ZI\L4\>UU'7//.?H:?;07$; SSJZJNU55%42<8ZY&*/L^;QIRW!C$>W\2?ZU/13LB>9E*ULY[?RHS.#!%G:H7!;TR?: MHSI"&)CN_P!(,GF>9SC=G/3]*T:*7(MBO:SO>Y3^S7$=Y--%)'MEVY#*